Company Filing History:
Years Active: 2001-2008
Title: The Innovative Contributions of Igor Beletsky
Introduction
Igor Beletsky, an accomplished inventor based in Pushino, Russia, has made significant strides in the field of biomedical research. With a total of five patents to his name, Beletsky’s work primarily focuses on therapeutic and diagnostic applications related to tumor necrosis factor receptors. His research is vital in the development of advanced immunoassays and treatments.
Latest Patents
Among Igor Beletsky's latest patents are novel methods pertaining to the determination of human TBP-II levels using anti-TBP-II antibodies. This patent outlines the applications of antibodies targeting tumor necrosis factor receptors (TNF-Rs) and provides methodologies for their production and use in immunoassays. Additionally, it covers the purification of TBP-II via affinity chromatography and introduces a diagnostic assay for identifying endogenous antibodies to TBP-II. Another significant patent encompasses the DNA molecule encoding TNF binding ligands, which illustrates the use of antibodies that inhibit the cytotoxic effects of TNF without interfering with its receptor binding. Specifically, these antibodies target the extracellular domain of the C-terminal cysteine loop of the p75 TNF receptor.
Career Highlights
Igor Beletsky's career is marked by his dedication to research and development in the biomedical field. Currently employed at Yeda Research and Development Co. Ltd., he has successfully contributed to groundbreaking research that has implications for both diagnostics and therapeutics. His work has not only demonstrated his inventive prowess but has also paved the way for future advancements in the understanding and treatment of various medical conditions.
Collaborations
Throughout his career, Igor Beletsky has collaborated with notable professionals in the field, including David Wallach and Jacek Bigda. These collaborations have enriched his research endeavors, fostering an environment of innovation and progression in the development of novel biomedical applications.
Conclusion
Igor Beletsky stands out as a prominent inventor whose contributions to the field of biomedical research are significant. With multiple patents highlighting his innovative approaches towards tumor necrosis factor receptors, his work promises to impact diagnostics and therapeutics positively. As he continues his journey at Yeda Research and Development Co. Ltd., the scientific community eagerly anticipates his future innovations.